JPRN-jRCT2080220302未知3 期
ong-term study of TA-8317 in patients with cancer breakthrough pain
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(Inclusion criteria)
- •Patients who are 20 years old or older.
- •Patients who are diagnosed and notified to have cancer.
- •Patients who are treated for persistent cancer pain with opioid analgesics, but experience breakthrough pain , etc.
- •(Exclusion criteria)
- •Patient's performance status scale (PS) is grade 4.
- •Patients with moderate to severe stomatitis , etc.
排除标准
- 未提供
研究者
相似试验
未知
3 期
ong-term study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222906Hisamitsu Pharmaceutical Co., Inc
未知
3 期
Confirmatory study of TA-8317 in patients with cancer breakthrough pain Open-label, crossover, comparative study using a comparator, morphine used as rescue medicatioCancer breakthrough painJPRN-jRCT2080220301Mitsubishi Tanabe Pharma Corporation
进行中（未招募）
1 期
Paediatric study of AT9283 in solid tumoursEUCTR2008-005542-23-GBCancer Research UK33
进行中（未招募）
1 期
AT9283 in children and adolescents with acute leukaemiaEUCTR2009-016952-36-GBCancer Research UK7
已完成
1 期
AT9283 in children and adolescents with acute leukaemiaCancerISRCTN97388141Cancer Research UK7